Source: BMC Veterinary Research. Unidade: FMVZ
Subjects: CÃES, NEOPLASIAS EM ANIMAL, CARCINOMA, NEOPLASIAS MAMÁRIAS, QUIMIOTERÁPICOS
ABNT
BORGHESI, Jéssica et al. Effects of doxorubicin associated with amniotic membrane stem cells in the treatment of canine inflammatory breast carcinoma (IPC-366) cells. BMC Veterinary Research, v. 16, p. 1-12, 2020Tradução . . Disponível em: https://doi.org/10.1186/s12917-020-02576-0. Acesso em: 04 out. 2024.APA
Borghesi, J., Cáceres, S., Mario, L. C., Alonso-Diez, A., Rabelo, A. C. S., Illera, M. J., et al. (2020). Effects of doxorubicin associated with amniotic membrane stem cells in the treatment of canine inflammatory breast carcinoma (IPC-366) cells. BMC Veterinary Research, 16, 1-12. doi:10.1186/s12917-020-02576-0NLM
Borghesi J, Cáceres S, Mario LC, Alonso-Diez A, Rabelo ACS, Illera MJ, Silvan G, Miglino MA, Favaron PO, Carreira ACO, Illera JC. Effects of doxorubicin associated with amniotic membrane stem cells in the treatment of canine inflammatory breast carcinoma (IPC-366) cells [Internet]. BMC Veterinary Research. 2020 ; 16 1-12.[citado 2024 out. 04 ] Available from: https://doi.org/10.1186/s12917-020-02576-0Vancouver
Borghesi J, Cáceres S, Mario LC, Alonso-Diez A, Rabelo ACS, Illera MJ, Silvan G, Miglino MA, Favaron PO, Carreira ACO, Illera JC. Effects of doxorubicin associated with amniotic membrane stem cells in the treatment of canine inflammatory breast carcinoma (IPC-366) cells [Internet]. BMC Veterinary Research. 2020 ; 16 1-12.[citado 2024 out. 04 ] Available from: https://doi.org/10.1186/s12917-020-02576-0